Researchers at NYU Dentistry’s Pain Research Center have been awarded a five-year, $8 million NIH grant to study signaling mechanisms that generate oral cancer pain. The funding is part of the NIH’s Helping to End Addiction Long-term Initiative, which supports the development of safe and effective therapeutics to treat pain in an effort to end the opioid crisis.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe